The Australian Financial Review: Clarity Pharma charges ahead on ASX debut

Sydney, Australia, 25 August 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Australian daily newspaper covering the latest business and economic affairs of Australia and the world. The article discusses Clarity’s ASX debut, its key investors and the company’s pipeline of products in development. Read the full article here: https://www.afr.com/companies/healthcare-and-fitness/clarity-pharma-charges-ahead-on-asx-debut-20210824-p58lev

The Australian Financial Review: Clarity Pharmaceuticals to hit ASX in August

Sydney, Australia, 21 July 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Australian daily newspaper covering the latest business and economic affairs of Australia and the world. The article discusses Clarity, our history, clinical trials, technology and the initial public offering on the Australian Securities Exchange. Read the full article here: https://www.afr.com/companies/healthcare-and-fitness/clarity-pharmaceuticals-to-hit-asx-in-august-20210720-p58b98

The Australian Financial Review: Terms out for Clarity’s $358m IPO

Sydney, Australia, 12 July 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Street Talk, the leading source of breaking news in Australia’s capital markets with live updates throughout the trading day. The article discusses the terms of Clarity’s initial public offering on the Australian Securities Exchange. Read the full article here: https://www.afr.com/street-talk/terms-out-for-clarity-s-358m-ipo-20210712-p588tj

The Australian: Clarity embarks on cornerstone process for IPO

Sydney, Australia, 8 July 2021 – Clarity Pharmaceuticals was featured in the Australian, Australia’s national broadsheet newspaper published by News Corp Australia since 14 July 1964. The article discusses Clarity’s initial public offering on the Australian Securities Exchange. Read the full article here: https://www.theaustralian.com.au/business/dataroom/clarity-pharmaceuticals-embarks-on-cornerstone-process-for-ipo/news-story/b2824850cb8686e039e68aecb9fafca2

The Australian Financial Review: Sirtex buyer China Grand looks to bankroll IPO candidate Clarity

Sydney, Australia, 8 July 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Street Talk, the leading source of breaking news in Australia’s capital markets with live updates throughout the trading day. The article discusses Clarity’s initial public offering on the Australian Securities Exchange and option agreement with China Grand Pharmaceuticals and Healthcare.…

The Australian Financial Review: Jefferies, Bells prepare cancer play Clarity for $300m float

Sydney, Australia 8 June 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Street Talk, the leading source of breaking news in Australia’s capital markets with live updates throughout the trading day. The article discusses Clarity’s initial public offering on the Australian Securities Exchange. Read the full article here: https://www.afr.com/street-talk/jefferies-bells-prepare-cancer-play-clarity-for-250m-float-20210608-p57z40

Idaho State University: ISU Idaho Accelerator Center announces record production of form of medical isotope copper-67 that will be used in cancer clinical trials

Clarity Pharmaceuticals was featured in Idaho State University News. The Idaho State University Accelerator Center is Clarity’s partner for the production of Copper-67. The article discusses the developments in copper-67 production and the positive effects it has on the expansion of our clinical development program. Read the full article here: https://www.isu.edu/news/2019-spring/isu-idaho-accelerator-center-announces-record-production-of-form-of-medical-isotope-copper-67-that-will-be-used-in-cancer-clinical-trials.html/

AUSinnovates: Precise, personalised cancer therapy cuts collateral damage

Clarity Pharmaceuticals was featured in AUSinnovates, a media project driven by gemaker that aims to stimulate research and innovation in Australia. The article sheds light on the story behind Clarity’s SAR Technology, discusses Clarity’s product pipeline and talks about the benefits of a collaborative approach to drug development.   Read the full article here: https://www.ausinnovates.com.au/clarity/  

Australian BioTechnology: Gender Equity in Life Sciences

  Clarity Pharmaceuticals was featured in Australasian BioTechnology, the journal of Ausbiotech, Australia’s life sciences industry organisation. The article, which was written by Clarity’s Lisa Sadetskaya, discusses the issues associated with gender in the life sciences and the benefits of creating gender-diverse teams. The article features Clarity as a case study, discussing practices that encourage…